Traumatic Brain Injury Assay Based on Serum Blood

  • Model name

    VEUPLEX™ TBI assay(V1-01A-2)

  • Company name

    Ezdiatech Inc.

  • Certification

    IVDD/IVDR,etc(Thailand FDA)

  • Exporting Country

    Europe,Southeast Asia

category

  • - CLINICAL & LABORATORY(IVD)

    • Immunochemistry & Immunology Testing

Company Detail
Product detail

VEUPLEX™ TBI assay detects two biomarkers (GFAP and UCH-L1) for patients suspected of traumatic brain injury (TBI) to provide quantitative results.
Compared to a CT scan that detects only 10% of mild TBI (concussion), VEUPLEX™ TBI assay with 95.15% sensitivity and 98.91% NPV ensures high accuracy for diagnosing TBI, especially mild TBI.
Compared to a CT scan that leads to long waiting times and a risk of radiation exposure, the VEUPLEX™ TBI assay provides results in approximately 50 minutes, enabling fast, safe, and precise detection of TBI-specific biomarkers for early TBI diagnosis and timely treatment for Post-Concussion Syndrome.

Before
Flowable Hemostatic Agent
After
Ultarsound Paper(Thermal Papers for Video Printer)